NCT03140826View on ClinicalTrials.gov

Amplification and Selection of Antimicrobial Resistance in the Intestine II

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Antibiotic Selection Pressure
Interventions
DRUG

meropenem

Antibiotics to treat infections.

Trial Locations (2)

50935

University Hospital Cologne, Cologne

72076

Institute of Medical Microbiology and Hygiene, University Hospital of Tuebingen, Tübingen

All Listed Sponsors
collaborator

University Hospital of Cologne

OTHER

lead

University Hospital Tuebingen

OTHER

NCT03140826 - Amplification and Selection of Antimicrobial Resistance in the Intestine II | Biotech Hunter | Biotech Hunter